Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry

First Page		Document Content
		Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 463,83 KB Share Document on Facebook